ICU Medical, Inc. (NASDAQ:ICUI) Shares Purchased by Cinctive Capital Management LP

Cinctive Capital Management LP boosted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 91.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 50,149 shares of the medical instruments supplier’s stock after acquiring an additional 23,954 shares during the quarter. Cinctive Capital Management LP owned about 0.20% of ICU Medical worth $7,782,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in shares of ICU Medical by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock valued at $416,176,000 after purchasing an additional 17,805 shares during the period. State Street Corp grew its position in ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after buying an additional 77,506 shares during the period. JPMorgan Chase & Co. increased its holdings in ICU Medical by 7.4% in the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock valued at $109,920,000 after buying an additional 49,108 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after acquiring an additional 48,106 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of ICU Medical by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier’s stock worth $47,196,000 after acquiring an additional 3,048 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on ICUI shares. Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. StockNews.com lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Thursday, March 27th. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $168.67.

Insider Activity at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 6.70% of the company’s stock.

ICU Medical Price Performance

ICUI stock opened at $137.80 on Wednesday. The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of -30.15 and a beta of 0.73. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 52-week low of $93.36 and a 52-week high of $196.26. The stock’s fifty day simple moving average is $153.34 and its 200-day simple moving average is $163.24.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.